Effects of RASAL2 on invasion and epithelial-masenchymal transition of gastric cancer

赵猛,赵晓朋,李峥,任丽
DOI: https://doi.org/10.3969/j.issn.1000-8179.2016.16.726
2016-01-01
Abstract:Objective:To investigates the effects of RASAL2 on invasion and migration of gastric cancer cells and the role of RASAL2 in epithelial-mesenchymal transition (EMT). Methods:SNU-1, SNU-16, and AGS gastric cancer cell lines were used as in vitro experimen-tal models. RNAi technology was used to establish stable RASAL2 knockdown cell lines, and RASAL2-expressing lentivirus was used to establish cells expressing upregulated RASAL2. To determine the impacts of RASAL2 on migration and invasion, we performed Tran-swell migration and invasion assay, together with wound healing assay. Immunofluorescence and Western blot assays were performed to explore the role of RASAL2 in EMT of gastric cancer cells. Furthermore, Western blot assay was performed to investigate the effects of RASAL2 on activation of Ras-ERK pathway. Results:Both target sites could significantly downregulate RASAL2 expression in SNU-16 and AGS cells. The number of migrating and invading cells decreased in cells expressing upregulated RASAL2 compared with that in scrambled controls. Similar results were obtained in wound healing assay. The epithelial marker E-cadherin was downregulated after RASAL2 knockdown, whereas the mesenchymal marker vimentin was upregulated. Snail, a transcriptional regulator of EMT, was also upregulated in RASAL2 knockdown cells. Ras-ERK pathway was activated after RASAL2 inhibition. Moreover, RASAL2 overexpression in SNU-1 inhibited cell migration. Conclusion:RASAL2 negatively regulates invasion and migration of gastric cancer cells and plays a vital role in EMT of these cells. The biological function of RASAL2 is at least partly dependent on Ras-ERK pathway.
What problem does this paper attempt to address?